Watchlist Price Alert

SAB Biotherapeutics Inc. (SABSW)

NASDAQ: SABSW · Real-Time Price · USD

0.03

0.00 (4.90%)

At close: May 12, 2025, 12:32 PM

SAB Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-34.11M	-42.19M	-17.14M	-17.14M	20.12M	-8.99M
Depreciation & Amortization	4.79M	3.75M	1.65M	1.65M	548.18K	323.41K
Stock-Based Compensation	2.94M	2.42M	2.67M	2.31M	1.3M	371.39K
Other Working Capital	-3.22M	-528.64K	3.83M	3.83M	100K	84.5K
Other Non-Cash Items	-5.62M	8.58M	3.48M	3.48M	-2	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.25K	421.00
Change in Working Capital	-2.3M	2.33M	13.45M	13.45M	-11.95M	-923.37K
Operating Cash Flow	-34.29M	-25.12M	3.76M	3.76M	10M	-9.21M
Capital Expenditures	-337.26K	-197.15K	-10.94M	-10.94M	-12.73M	-608.75K
Cash Acquisitions	n/a	n/a	76.39K	n/a	9K	n/a
Purchase of Investments	-37.45M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	25.82M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-337.26K	44.45K	-76.39K	-10.94M	n/a	n/a
Investing Cash Flow	-11.96M	-152.7K	-10.94M	-10.94M	-12.72M	-608.75K
Debt Repayment	-907K	-390.44K	-1.19M	1.54M	-917.88K	n/a
Common Stock Repurchased	n/a	n/a	-5.52M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-265.63K	59.66M	76.97K	32.58M	n/a	-4.3M
Financial Cash Flow	-1.17M	66.77M	34.12M	34.12M	8.98M	3.68M
Net Cash Flow	-47.67M	41.52M	26.93M	26.93M	6.26M	-6.14M
Free Cash Flow	-34.63M	-25.32M	-7.19M	-7.19M	-2.73M	-9.82M